glp 1 cost reduction The future of GLP-1s: Cost, access and more trends HR must know GLP-1s are no longer the

This limits their compatibility to an extent

van der Klaauw et al., "Role of melanocortin signalling in the preference for dietary macronutrients in human beings," Lancet Lond

Early reports suggest possible benefits in conditions such as psoriasis and hidradenitis suppurativa, especially in patients who also have obesity, insulin resistance or type 2 diabetes

Quadrupling the dose did not buy a meaningful gain

Research designs occasionally use both compounds together for specific comparative studies particularly research investigating the effects of selective vs non-selective melanocortin agonism

PMID: 19001026, DOI: 10.1161/circulationaha.108.191100